title: [Mast cells, their adenosine receptors and reactive oxygen species in chronic inflammatory pathologies of childhood].
abstract: Mast cells were described by Erhlich at the end of XIX-th century. Their role was deeply investigated in asthma and allergy. The massive degranulation of mast cells in allergy can lead to anaphylactic shock. Recently, mast cells have been recognized again as a very interesting topic for investigation, due to their possible role in chronic inflammation. Moreover, through adenosine receptors, mast cells can be activated or inactivated. That is why these cells are regarded as a potential target of new drugs. It has been reported, that mast cells generate intracellular reactive oxygen species (ROS) in response to stimulation with divergent physiologically relevant stimulants. The intensification of ROS production may be measured by the level of carbonyl groups, as a marker of protein peroxidation. However, the role of mast cells in other than asthma diseases with chronic inflammation needs further investigation. It was found out that the information about mast cell distribution in colonic mucosa may serve as help in differentiation between inflammatory bowel disease and collagenous colitis. Moreover, its accumulation in focal active gastritis was confirmed in patients with Crohn's disease. An important role in regulation of inflammatory process seems to be reserved for adenosine receptors present on mastocytes. The activation of mast cells through the adenosine receptor is connected with 11-8 release, which stimulate the migration of leukocytes and oxidation reactions. The detection of mast cells in tissues should not be limited only to the simple histologic examination. It should be completed by the detection of products of degranulation, e.g. tryptase. This is the way to find out their actual function and state of activation.
authors.affiliation: Klinika Pediatrii, Gastroenterologii i Onkologii, Dzieciecej Akademii Medycznej w Gdańsku. jrenke@amg.gda.pl
authors.forename: Joanna
authors.initials: J
authors.lastname: Renke
authors.forename: Stefan
authors.initials: S
authors.lastname: Popadiuk
authors.forename: Michał
authors.initials: M
authors.lastname: Wozniak
authors.forename: Agnieszka
authors.initials: A
authors.lastname: Szlagatys-Sidorkiewicz
authors.forename: Rita
authors.initials: R
authors.lastname: Hansdorfer-Korzon
mesh_terms: D000328:Adult; D000818:Animals; D001249:Asthma / Q000276:immunology*; D015550:Cell Degranulation / Q000276:immunology; D002648:Child; D002908:Chronic Disease; D006801:Humans; D006967:Hypersensitivity / Q000276:immunology*; D007249:Inflammation / Q000276:immunology*; D015212:Inflammatory Bowel Diseases / Q000276:immunology* / Q000628:therapy; D008407:Mast Cells / Q000276:immunology* / Q000473:pathology; D010084:Oxidation-Reduction; D017382:Reactive Oxygen Species / Q000378:metabolism*; D018047:Receptors, Purinergic P1 / Q000378:metabolism*
chemical_list: D017382:Reactive Oxygen Species; D018047:Receptors, Purinergic P1